Table 1.
Mean or Percent | Standard Error | 95% CI | |
---|---|---|---|
Age (y) | 49.59 | 1.30 | 46.97–52.20 |
Gender (% male) | 47.07 | 0.71 | 45.64–48.51 |
Race/ethnicity (%) | |||
Non-Hispanic white | 77.27 | 2.28 | 72.69–81.85 |
Non-Hispanic black | 10.05 | 1.13 | 7.79–12.32 |
Mexican-American | 4.76 | 0.77 | 3.21–6.31 |
Other | 7.92 | 1.45 | 4.99–10.84 |
Poverty-income ratio | 3.17 | 0.10 | 2.97–3.37 |
Highest grade completed | 12.23 | 0.14 | 11.93–12.52 |
Self-reported health status (%) | |||
Excellent | 18.64 | 0.96 | 16.70–20.58 |
Very good | 30.48 | 1.12 | 28.23–32.73 |
Good | 33.43 | 0.81 | 31.80–36.05 |
Fair | 14.03 | 1.01 | 12.01–16.05 |
Poor | 3.37 | 0.30 | 2.76–3.97 |
eGFR (mL/min) | 106.21 | 1.19 | 103.82–108.60 |
Chronic kidney disease (%) | |||
Stage 1/2 | 9.66 | 0.65 | 8.36–10.97 |
Stage 3A | 1.80 | 0.21 | 1.39–2.22 |
Stage 3B-5 | 1.10 | 0.14 | 0.83–1.38 |
Diabetes (%) | 13.01 | 0.85 | 11.30–14.71 |
Cancer (%) | 4.75 | 0.45 | 3.85–5.65 |
COPD (%) | 8.29 | 0.44 | 7.41–9.18 |
Liver disease (%) | 8.96 | 0.64 | 7.67–10.25 |
Arthritis (%) | 22.84 | 1.50 | 19.83–25.85 |
25 hydroxy vitamin D concentration, serum (ng/mL) | 29.38 | 0.55 | 28.27–30.49 |
Hemoglobin (g/dL) | 14.20 | 0.04 | 14.11–14.28 |
Bicarbonate, serum (mmol/L) | 27.62 | 0.24 | 27.15–28.10 |
C-reactive protein, serum (units) | 0.44 | 0.01 | 0.41–0.46 |
Hypertensiona (%) | 35.06 | 1.97 | 31.11–39.01 |
Overt cardiovascular diseaseb (%) | 12.65 | 0.92 | 10.80–14.51 |
CI = confidence interval; eGFR = estimated glomerular filtration rate; COPD = chronic obstructive pulmonary disease.
Joint National Committee 7 guidelines.
Composite measure of peripheral arterial disease, coronary artery disease, congestive heart failure, and history of cerebrovascular accident.